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Letter
A widely used sampling device 
in colorectal cancer screening 
programmes allows for large-
scale microbiome studies
We read with interest the article by 
Passamonti et al,1 reporting the perfor-
mance of two different faecal immu-
nochemical tests (FITs) highlighting the 
importance of standardisation and valida-
tion of screening methodologies. Conven-
tionally, laboratory-based FIT is the 
preferred approach in testing for occult 
blood in faeces, which includes colorectal 
cancer screening programmes.2–4 The 
potential of preserving stable faecal 
samples in a widely used FIT buffer 
for microbiome research would enable 
prospective microbiome studies in gener-
ally healthy subjects undergoing colorectal 
cancer screening.
For this purpose, we evaluated faecal 
sample stability in the commonly used 
OC-Sensor (Eiken Chemical, Tokyo, 
Japan) under various storage conditions. 
Faecal samples from five healthy adult 
individuals were used for the analysis and 
exposed to 16 different conditions: imme-
diately frozen at −86°C (with FIT (wFIT)/
without FIT (woFIT)); immediately frozen 
at −20°C (wFIT/woFIT); wFIT stored at 
4°C for 1, 2, 7, 14 days; stored at 20°C for 
1, 2, 7, 14 days; stored at 30°C for 1, 2, 
7 days and lastly stored at 4°C for 2 days 
and at 20°C for additional 2 days. Shotgun 
metagenomic analysis was performed by 
Illumina 2500, while taxonomic composi-
tions were determined by 16S rRNA anal-
ysis employing Illumina MiSeq and Ion 
Torrent PGM.
Our first attempt to extract DNA from 
wFIT samples failed due to low amount 
of DNA obtained. Thus, lyophilisation for 
all of the wFIT samples, except for woFIT 
samples, was applied, increasing the yield 
of DNA up to 30 times.
As shown by the figure 1, the Shannon 
index in both platforms displayed a clear 
pattern of decreased diversity during 
prolonged storage. While testing for differ-
ences between samples we discovered that 
woFIT samples, wFIT samples stored 
at 4°C for 1 and 2 days, wFIT samples 
stored at 20°C for 1 day from the Illumina 
MiSeq data significantly differ from wFIT 
samples stored at 30°C for 7 days (one-
way analysis of variance; p<0.05).
The similarity matrix using unweighted 
principal coordinate analysis (PCoA, 
figure 2A,C) demonstrated that samples 
collected from each individual clus-
tered together and was consistent in 
data gained from both sequencing plat-
forms, suggesting that the biological 
effect outweighed the effect of the sample 
handling. Further, the weighted PCoA 
(figure 2B,D) displays that native samples 
tend to cluster closer while samples stored 
for prolonged periods tend to be located 
further away from the native ones.
Comparing observed operational taxo-
nomic units (OTUs) between samples 
that were stored within various storage 
conditions, we were unable to identify any 
specific OTU cluster across all taxonom-
ical levels that would significantly differ 
(Kruskal-Wallis test) between any storage 
condition. Nevertheless, we found that 
the relative abundances of Gram-nega-
tive bacteria tended to decrease while the 
abundances for most of the Gram-pos-
itive bacteria tended to increase over 
time. However, it is possible that even 
within native samples certain bacterial 
OTUs could fluctuate regardless of the 
sequencing platform employed.
Shotgun sequencing was performed on 
12 samples (figure 2E) from four individ-
uals: six woFIT samples (WO1–4) that 
were immediately stored at −86°C and 
six wFIT samples from three individuals 
(FIT1–4), stored for 2 days at 4°C and 
for 2 days at 20°C to imitate the typical 
sample treatment procedure when the 
material is being transported to a central 
laboratory by standard mail delivery. In 
addition to access the reproducibility of 
acquired data, technical replicates in the 
form of DNA that was extracted from 
independently collected samples from 
individuals 2 and 3 were included within 
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Figure 1 Mean Shannon diversity index values by storage conditions of faecal samples sequenced on Ion Torrent Personal Genome Machine and 
Illumina MiSeq. Error bars represent SEs. FIT, faecal immunochemical test. 
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this analysis. However, two wFIT samples 
(eg, FIT2.2 and FIT4) failed during the 
sequencing stage and therefore were 
excluded from further analysis. A simi-
larity matrix was built with relative abun-
dances to calculate the PCoA. Figure 2E 
illustrates the similarity between species 
for two types of sampling showing that 
results are not biased to the sampling 
procedures. Results indicate that sample 
similarities tended towards samples from 
the same subject rather than the storage 
method.
In this study, we sequenced micro-
biome samples employing two different 
sequencing platforms—Ion Torrent 
PGM that allows to analyse one variable 
region (V3) and to verify acquired results 
and also Illumina MiSeq platform that 
enables the analysis of two variable 
regions (V3–V4) at a time. Analysing abso-
lute OTU frequencies within the samples, 
we did not find a significant difference 
between immediately frozen samples, 
which coincide with previous studies.5–8 
Although previous study9 has found lower 
FIT stability measures, we observed some 
limitations as they extracted DNA from a 
small proportion of sample, while in our 
study design lyophilisation procedure 
was included allowing to extract DNA 
from whole volume. However, we did not 
include technical replicates for 16S rRNA 
analysis. Another critical aspect in FIT-ori-
ented studies is the variety of available FIT 
test tubes in the market. Each FIT buffer 
from various manufacturers might contain 
slightly different ingredients and concen-
trations,10 which seems to be a trade secret 
and might alter the microbial composi-
tion. In our study, employed OC-Sensor is 
a reliable and convenient sampling device 
that can be used in large-scale microbiome 
studies on a population level even outside 
colorectal cancer screening programmes.
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Figure 2 Beta diversity (panels A–D) analysis of GI tract bacterial communities between the individuals and storage conditions presented in a form 
of principal coordinate analysis (PCoA) plot of weighted and unweighted UniFrac distances. Panels A and C are coloured according to the individual, 
panels B and D are coloured according to the conditions that samples were exposed to. Panels A and B represent the UniFrac metrics obtained from 
sequencing on the Illumina MiSeq platform, whereas panels C and D represent UniFrac metrics obtained from sequencing on the Ion Torrent PGM 
platform. The results of the metagenomics analysis at the species level are presented within panel E in a form of the heat-map profile for the most 
abundant entities in the metagenome samples. According to upper dendrogram, there is a consistency within the samples composition as the samples 
from the same individual are clustering together. Samples WO1, WO2.1, WO2.2, WO3.1, WO3.2, WO4 were without faecal immunochemical test 
(woFIT) and immediately frozen at −86°C; while samples FIT1, FIT2.1, FIT2.2, FIT3.1, FIT3.2 and FIT4 were with FIT (wFIT) and stored at 4°C for 2 
days and then at 20°C for additional 2 days. Samples FIT2.2 and FIT4 failed at the sequencing stage and therefore are not presented within the figure. 
Both sample groups include technical replicates for individuals 2 and 3 (eg, WO2.1. and WO2.2.; WO3.1 and WO3.2.; FIT2.1 and FIT2.2.; FIT3.1. and 
FIT3.2.).
 o
n
 22 February 2019 by guest. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2018-316225 on 21 September 2018. Downloaded from 
3Gut Month 2018 Vol 0 No 0
PostScript
Ethics approval Biomedical ethics Committee of 
the riga east University Hospital Support Foundation, 
approval no: 13-A/13.
Provenance and peer review Not commissioned; 
externally peer reviewed.
Open access this is an open access article 
distributed in accordance with the Creative Commons 
Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build 
upon this work non-commercially, and license their 
derivative works on different terms, provided the 
original work is properly cited, appropriate credit is 
given, any changes made indicated, and the use is 
non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/.
© Author(s) (or their employer(s)) 2018. re-use 
permitted under CC BY-NC. No commercial re-use. See 
rights and permissions. Published by BMJ.
ML and Le contributed equally.
DG and SS contributed equally.
To cite Gudra D, Shoaie S, Fridmanis D, et al. Gut epub 
ahead of print: [please include Day Month Year]. 
doi:10.1136/gutjnl-2018-316225
Received 9 February 2018
revised 8 August 2018
Accepted 26 August 2018
Gut 2018;0:1–3. doi:10.1136/gutjnl-2018-316225
RefeRences
 1 Passamonti B, Malaspina M, Fraser CG, et al. 
A comparative effectiveness trial of two faecal 
immunochemical tests for haemoglobin (FIt). 
Assessment of test performance and adherence 
in a single round of a population-based 
screening programme for colorectal cancer. Gut 
2018;67:485–96.
 2 Directorate-General for Health and Consumers 
(european Commission) eAfHaC, World Health 
Organization. European guidelines for quality 
assurance in colorectal cancer srceening and diagnosis. 
Luxemborug, 2010.
 3 Young GP, Symonds eL, Allison Je, et al. Advances in 
fecal occult blood tests: the FIt revolution. Dig Dis Sci 
2015;60:609–22.
 4 robertson DJ, Lee JK, Boland Cr, et al. 
recommendations on fecal immunochemical testing to 
screen for colorectal neoplasia: a consensus statement 
by the us multi-society task force on colorectal cancer. 
Am J Gastroenterol 2017;112:37–53.
 5 Hale VL, tan CL, Knight r, et al. effect of preservation 
method on spider monkey (Ateles geoffroyi) fecal 
microbiota over 8 weeks. J Microbiol Methods 
2015;113:16–26.
 6 Carroll IM, ringel-Kulka t, Siddle JP, et al. 
Characterization of the fecal microbiota using high-
throughput sequencing reveals a stable microbial 
community during storage. PLoS One 2012;7:e46953.
 7 Vlčková K, Mrázek J, Kopečný J, et al. evaluation of 
different storage methods to characterize the fecal 
bacterial communities of captive western lowland 
gorillas (Gorilla gorilla gorilla). J Microbiol Methods 
2012;91:45–51.
 8. Cardona S, eck A, Cassellas M, et al. Storage 
conditions of intestinal microbiota matter in 
metagenomic analysis. BMC Microbiol  
2012;12:158.
 9 Vogtmann e, Chen J, Kibriya MG, et al. Comparison 
of fecal collection methods for microbiota 
studies in Bangladesh. Appl Environ Microbiol 
2017;83:e00361–17.
 10 Grow MA, Shah VD. Fecal sample immunoassay 
method testing for hemoglobin. european Patent 
Office., 1993.
 o
n
 22 February 2019 by guest. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2018-316225 on 21 September 2018. Downloaded from 
